Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.57
+0.5%
$114.00
$89.67
$121.64
$186.65B0.745.73 million shs3.85 million shs
General Motors stock logo
GM
General Motors
$45.10
+4.4%
$41.86
$26.30
$46.04
$52.06B1.5117.59 million shs28.61 million shs
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
$0.87
-5.4%
$1.53
$0.65
$15.47
$22.56MN/A386,755 shs166,726 shs
General Motors stock logo
GMM.U
General Motors
C$0.00
C$43.20
C$43.88
N/AN/AN/AN/A
The Gap, Inc. stock logo
GPS
GAP
$20.91
+0.8%
$22.55
$7.22
$28.59
$7.81B2.287.55 million shs5.77 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.32
+0.2%
$27.07
$25.23
$40.37
$149.04B0.6142.11 million shs24.29 million shs
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$40.40
+3.4%
$44.76
$37.78
$95.02
$2.61B0.111.01 million shs1.19 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.47%-1.49%-2.71%-2.89%-2.56%
General Motors stock logo
GM
General Motors
+4.28%+5.74%+4.74%+29.97%+31.53%
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
-5.33%+1.87%-3.33%-73.07%+86,999,900.00%
The Gap, Inc. stock logo
GPS
GAP
+0.75%-0.33%-25.55%+10.14%+107.60%
Pfizer Inc. stock logo
PFE
Pfizer
+0.23%+2.45%-3.80%-7.09%-34.05%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
+3.38%+0.25%-13.68%-42.28%-56.37%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9934 of 5 stars
3.35.04.24.52.52.52.5
General Motors stock logo
GM
General Motors
4.8153 of 5 stars
3.43.02.50.03.12.53.8
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
N/AN/AN/AN/AN/AN/AN/AN/A
General Motors stock logo
GMM.U
General Motors
N/AN/AN/AN/AN/AN/AN/AN/A
The Gap, Inc. stock logo
GPS
GAP
3.8094 of 5 stars
2.22.02.51.01.33.32.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9942 of 5 stars
3.25.04.24.82.51.73.1
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
4.9504 of 5 stars
4.05.00.03.82.33.32.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5012.95% Upside
General Motors stock logo
GM
General Motors
2.80
Moderate Buy$52.5216.44% Upside
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
N/AN/AN/AN/A
General Motors stock logo
GMM.U
General Motors
N/AN/AN/AN/A
The Gap, Inc. stock logo
GPS
GAP
2.36
Hold$18.89-9.65% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.3338.04% Upside
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
2.00
Hold$61.6052.48% Upside

Current Analyst Ratings

Latest ABT, GMM, GM, GMM.U, PFE, QDEL, and GPS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/23/2024
General Motors stock logo
GM
General Motors
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$44.00 ➝ $50.00
4/23/2024
General Motors stock logo
GM
General Motors
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$54.00 ➝ $56.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/11/2024
General Motors stock logo
GM
General Motors
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$50.00 ➝ $55.00
4/10/2024
General Motors stock logo
GM
General Motors
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$43.00 ➝ $46.00
4/4/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$120.00 ➝ $125.00
4/3/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$126.00 ➝ $128.00
4/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.65$6.38 per share16.86$22.36 per share4.81
General Motors stock logo
GM
General Motors
$171.84B0.30$20.78 per share2.17$59.07 per share0.76
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
$26.89M0.84$0.25 per share3.52N/A
General Motors stock logo
GMM.U
General Motors
N/AN/AN/AN/AN/AN/A
The Gap, Inc. stock logo
GPS
GAP
$14.89B0.52$2.88 per share7.25$7.00 per share2.99
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.55$3.01 per share8.74$15.81 per share1.66
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$3.00B0.90$11.35 per share3.56$74.92 per share0.54

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.5121.012.5813.96%20.32%10.59%7/18/2024 (Estimated)
General Motors stock logo
GM
General Motors
$10.13B$7.316.174.880.505.89%14.34%3.87%N/A
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
$6.55MN/A0.00N/AN/AN/AN/AN/A
General Motors stock logo
GMM.U
General Motors
N/AN/A0.00N/AN/AN/AN/AN/AN/A
The Gap, Inc. stock logo
GPS
GAP
$502M$1.3415.6013.941.273.37%22.56%4.89%5/23/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3673.119.501.173.62%10.88%4.91%5/1/2024 (Confirmed)
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
-$10.10M-$0.16N/A10.15N/A-0.34%5.54%3.21%5/8/2024 (Confirmed)

Latest ABT, GMM, GM, GMM.U, PFE, QDEL, and GPS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$0.54N/A-$0.54N/AN/AN/A  
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/23/2024Q1 24
General Motors stock logo
GM
General Motors
$2.02$2.62+$0.60N/A$41.09 billion$43.01 billion      
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
3/7/2024Q4 23
The Gap, Inc. stock logo
GPS
GAP
$0.20$0.49+$0.29$0.49$4.22 billion$4.30 billion    
2/13/2024Q4 2023
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
$2.01$1.17-$0.84$2.24$796.91 million$742.60 million    
1/30/202412/31/2023
General Motors stock logo
GM
General Motors
$1.16$1.24+$0.08$0.89$38.81 billion$42.98 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    
1/24/202412/31/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.19$1.19N/A$1.47$10.19 billion$10.24 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.05%+12.31%68.54%53 Years
General Motors stock logo
GM
General Motors
$0.481.06%-1.79%6.57%1 Years
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
N/AN/AN/AN/AN/A
General Motors stock logo
GMM.U
General Motors
N/AN/AN/AN/AN/A
The Gap, Inc. stock logo
GPS
GAP
$0.602.87%+35.25%44.78%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.38%+2.57%466.67%15 Years
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
N/AN/AN/AN/AN/A

Latest ABT, GMM, GM, GMM.U, PFE, QDEL, and GPS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2024
General Motors stock logo
GM
General Motors
quarterly$0.121.11%6/7/20246/7/20246/20/2024
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
2/27/2024
The Gap, Inc. stock logo
GPS
GAP
quarterly$0.153.05%4/9/20244/10/20245/1/2024
1/29/2024
General Motors stock logo
GM
General Motors
quarterly$0.121.36%2/29/20243/1/20243/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
General Motors stock logo
GM
General Motors
1.21
1.08
0.90
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
N/A
3.11
3.11
General Motors stock logo
GMM.U
General Motors
N/AN/AN/A
The Gap, Inc. stock logo
GPS
GAP
0.57
1.42
0.78
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
0.45
1.57
0.88

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
General Motors stock logo
GM
General Motors
92.67%
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
2.48%
General Motors stock logo
GMM.U
General Motors
N/A
The Gap, Inc. stock logo
GPS
GAP
58.81%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
99.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
General Motors stock logo
GM
General Motors
163,0001.15 billion1.15 billionOptionable
Global Mofy Metaverse Limited stock logo
GMM
Global Mofy Metaverse
3825.93 millionN/ANot Optionable
General Motors stock logo
GMM.U
General Motors
N/AN/AN/ANot Optionable
The Gap, Inc. stock logo
GPS
GAP
85,000373.51 million257.72 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable
QuidelOrtho Co. stock logo
QDEL
QuidelOrtho
7,10066.88 million66.21 millionOptionable

ABT, GMM, GM, GMM.U, PFE, QDEL, and GPS Headlines

SourceHeadline
Private Management Group Inc. Boosts Stock Position in QuidelOrtho Co. (NASDAQ:QDEL)Private Management Group Inc. Boosts Stock Position in QuidelOrtho Co. (NASDAQ:QDEL)
marketbeat.com - April 23 at 10:25 PM
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact Levi & KorsinskyClass Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact Levi & Korsinsky
accesswire.com - April 23 at 9:35 PM
QDEL May 2024 50.000 callQDEL May 2024 50.000 call
uk.finance.yahoo.com - April 23 at 5:47 PM
QDEL May 2024 40.000 putQDEL May 2024 40.000 put
uk.finance.yahoo.com - April 23 at 5:47 PM
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyLost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
accesswire.com - April 23 at 5:20 PM
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrtho Lawsuit - QDELLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrtho Lawsuit - QDEL
accesswire.com - April 23 at 5:20 PM
Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDELInvestors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
accesswire.com - April 23 at 12:00 PM
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the FirmINVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
prnewswire.com - April 23 at 11:15 AM
Contact Levi & Korsinsky by June 11, 2024 Deadline to Join Class Action Against QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)Contact Levi & Korsinsky by June 11, 2024 Deadline to Join Class Action Against QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)
accesswire.com - April 23 at 5:30 AM
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineQDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
accesswire.com - April 23 at 5:30 AM
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) ShareholdersLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Shareholders
accesswire.com - April 22 at 6:30 PM
Lost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyLost Money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
accesswire.com - April 22 at 6:30 PM
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class Action - QDELShareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL
accesswire.com - April 22 at 4:00 PM
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the FirmSHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
markets.businessinsider.com - April 22 at 3:37 PM
QuidelOrtho Corporation (QDEL) Investor Notice: Robbins LLP Reminds Stockholders of the QuidelOrtho Corporation Shareholder Class ActionQuidelOrtho Corporation (QDEL) Investor Notice: Robbins LLP Reminds Stockholders of the QuidelOrtho Corporation Shareholder Class Action
businesswire.com - April 22 at 2:58 PM
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact Levi & KorsinskyClass Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact Levi & Korsinsky
accesswire.com - April 22 at 7:35 AM
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the FirmDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
accesswire.com - April 22 at 7:00 AM
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - QDELQuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - QDEL
accesswire.com - April 22 at 6:15 AM
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact Levi & Korsinsky about pending Class Action - QDELShareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact Levi & Korsinsky about pending Class Action - QDEL
accesswire.com - April 22 at 6:15 AM
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineQDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
prnewswire.com - April 22 at 5:45 AM
Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - QDELLevi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - QDEL
accesswire.com - April 22 at 5:00 AM
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
prnewswire.com - April 22 at 4:00 AM
QuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDELQuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
accesswire.com - April 22 at 2:30 AM
QuidelOrtho Co. Forecasted to Earn Q1 2024 Earnings of $0.24 Per Share (NASDAQ:QDEL)QuidelOrtho Co. Forecasted to Earn Q1 2024 Earnings of $0.24 Per Share (NASDAQ:QDEL)
americanbankingnews.com - April 22 at 1:20 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
General Motors logo

General Motors

NYSE:GM
General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.
Global Mofy Metaverse logo

Global Mofy Metaverse

NASDAQ:GMM
Global Mofy Metaverse Limited, through its subsidiaries, provides virtual content production, digital marketing, and digital assets development services for the metaverse industry in the People's Republic of China. It offers services for visual effect design, content development, production, and integration based on customers specific needs; and 3D rebuilt and artificial intelligence technologies using its Mofy Lab technology platform. The company also grants use right of digital assets for various applications, such as movies, TV series, AR/VR, animation, advertising, and gaming. Global The company was incorporated in 2021 and is headquartered in Beijing, the People's Republic of China.
General Motors logo

General Motors

TSE:GMM.U
GAP logo

GAP

NYSE:GPS
The Gap, Inc. operates as an apparel retail company. The company offers apparel, accessories, and personal care products for men, women, and children under the Old Navy, Gap, Banana Republic, and Athleta brands. Its products include adult apparel and accessories; and fitness and lifestyle products for use in yoga, training, sports, travel, and everyday activities for women and girls. The company offers its products through company-operated stores, franchise stores, websites, and third-party arrangements. It has franchise agreements to operate Old Navy, Gap, Banana Republic, and Athleta stores and websites in Asia, Europe, Latin America, the Middle East, and Africa. The Gap, Inc. was incorporated in 1969 and is headquartered in San Francisco, California.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
QuidelOrtho logo

QuidelOrtho

NASDAQ:QDEL
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.